New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 10, 2014
04:55 EDTTHOR, THOR, THOR, THOR, HTWR, HTWR, HTWR, HTWR, GILD, GILD, GILD, GILD, DNA, DNA, DNA, DNA, BAYRY, BAYRY, BAYRY, BAYRY, ALIOF, ALIOF, ALIOF, ALIOF, SSH, SSH, SSH, SSH, UTHR, UTHR, UTHR, UTHRInternational Society for Heart & Lung Transplantation to hold annual meeting
34th Annual Meeting of ISHLT is being held in San Diego, California on April 10-13.
News For THOR;HTWR;GILD;DNA;BAYRY;ALIOF;SSH;UTHR From The Last 14 Days
Check below for free stories on THOR;HTWR;GILD;DNA;BAYRY;ALIOF;SSH;UTHR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 22, 2014
09:36 EDTGILDActive equity options trading on open
Subscribe for More Information
August 21, 2014
07:57 EDTGILDGilead HCV risks overblown, says Bernstein
Bernstein believes that investors are concerned about upcoming competition to Gilead's (GILD) HCV drug from AbbVie's (ABBV) HCV treatment. But Bernstein says that insurers can only prevent 16% of the U.S. population from receiving Gilead's drug, and the firm does not expect the HCV market share dynamics to change in the near-term. It keeps an Outperform rating on Gilead.
August 19, 2014
16:00 EDTGILDOptions Update; August 19, 2014eBay
iPath S&P 500 VIX Short-Term Futures down 28c to 27.52. Option volume leaders: AAPL C HD PBR GILD AA NFLX TWTR TSLA EBAY according to Track Data.
09:38 EDTGILDActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD TSLA CELG VLO VZ FB HD
August 18, 2014
16:00 EDTGILDOptions Update; August 18, 2014
Subscribe for More Information
11:41 EDTUTHRCubist rises after report sparks takeover interest speculation
Subscribe for More Information
09:35 EDTGILDActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AMZN DG TSLA GILD FB ABX WFC C
August 15, 2014
16:00 EDTGILDOptions Update; August 15, 2014
iPath S&P 500 VIX Short-Term Futures up 1c to 28.88. Option volume leaders: AAPL GILD NFLX PBR TWTR TSLA MNKD AMZN C according to Track Data.
10:01 EDTGILDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:18 EDTGILDGilead initiated with an Outperform at FBR Capital
Subscribe for More Information
06:12 EDTGILDGilead announced favorable ruling in arbitration against Roche
Gilead (GILD) announced that an arbitration panel determined that Roche (RHHBY) failed to establish any of their claims and ruled in favor of Gilead. As a result, Roche is not entitled to any damages or other relief. In March 2013, Roche initiated an arbitration against Gilead and Pharmasset, predecessor to Gilead Pharmasset, regarding a 2004 collaboration agreement between Roche and Pharmasset. In the arbitration demand, Roche asserted that it had an exclusive license to sofosbuvir pursuant to the collaboration agreement because sofosbuvir, a prodrug of a uridine monophosphate analog, is allegedly a prodrug of PSI-6130, a cytidine analog. Roche further claimed that, because it had exclusive rights to sofosbuvir, it also had an exclusive license to a patent covering sofosbuvir, and that we infringed that patent by selling and offering for sale products containing sofosbuvir.
August 14, 2014
16:01 EDTGILDOptions Update; August 14, 2014
Subscribe for More Information
August 13, 2014
13:13 EDTALIOFInterMune exploring sale after bids from Sanofi, Roche, Glaxo, Bloomberg says
InterMune (ITMN) is working with its financial advisers Goldman Sachs (GS) and Centerview Partners to evaluate takeover bids it has received from Sanofi (SNY), Roche (RHHBY), GlaxoSmithKline (GSK) and Actelion (ALIOF), said Bloomberg, citing people with knowledge of the matter. The report noted that one of the sources said Sanofi has so far shown the most interest in a deal for InterMune, whose shares are up more than 13% to $51.56 following the first headlines from the report. Reference Link
09:37 EDTGILDActive equity options trading on open
Subscribe for More Information
August 12, 2014
05:39 EDTSSHSunshine Heart reports Q2 EPS (38c), consensus (40c)
Reports Q2 revenue $0, consensus $130,000.
August 11, 2014
10:19 EDTTHOROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:36 EDTGILDActive equity options trading on open
Subscribe for More Information
08:21 EDTTHORThoratec downgraded to Market Perform from Outperform at Northland
07:29 EDTGILDGilead price target raised to $110 from $90 at Argus
Subscribe for More Information
05:32 EDTBAYRYRegeneron Eylea injection receives EU approval for DME treatment
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use